Kai-wen F. Hsu

Taitung, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

A miR-124-3p/PKC-δ Regulatory Axis Restrains Bladder Cancer Growth and Malignant Progression.

A miR-124-3p/PKC-δ Regulatory Axis Restrains Bladder Cancer Growth and Malignant Progression.

Journal: In vivo (Athens, Greece)

Published: March 26, 2026

Integrative multi-omics and preclinical analyses identify miR-4776-5p as a prognostic radiosensitizer for patients undergoing radiotherapy for head-and-neck cancer.

Integrative multi-omics and preclinical analyses identify miR-4776-5p as a prognostic radiosensitizer for patients undergoing radiotherapy for head-and-neck cancer.

Journal: Discover oncology

Published: July 16, 2025

Scaffolding of the H4K5ac chromatin remodeling complex by lncRNA MAHAC mediates epithelial-mesenchymal transition.

Scaffolding of the H4K5ac chromatin remodeling complex by lncRNA MAHAC mediates epithelial-mesenchymal transition.

Journal: Nucleic acids research

Published: June 30, 2025

ALKBH4 functions as a hypoxia-responsive tumor suppressor and inhibits metastasis and tumorigenesis.

ALKBH4 functions as a hypoxia-responsive tumor suppressor and inhibits metastasis and tumorigenesis.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: October 06, 2024

Targeting the USP7-CDK1 axis suppresses estrogen receptor-positive breast cancer progression.

Targeting the USP7-CDK1 axis suppresses estrogen receptor-positive breast cancer progression.

Journal: Cancer cell international

Published: July 23, 2024

TESC associated with poor prognosis enhances cancer stemness and migratory properties in liver cancer.

TESC associated with poor prognosis enhances cancer stemness and migratory properties in liver cancer.

Journal: Clinical and experimental medicine

Published: July 01, 2024

PPIH as a poor prognostic factor increases cell proliferation and m6A RNA methylation in hepatocellular carcinoma.

PPIH as a poor prognostic factor increases cell proliferation and m6A RNA methylation in hepatocellular carcinoma.

Journal: American journal of cancer research

Published: June 10, 2024

G-cleave LC3B biosensor: monitoring autophagy and assessing resveratrol's synergistic impact on doxorubicin-induced apoptosis in breast cancer cells.

G-cleave LC3B biosensor: monitoring autophagy and assessing resveratrol's synergistic impact on doxorubicin-induced apoptosis in breast cancer cells.

Journal: Breast cancer research : BCR

Published: March 29, 2024

Unveiling IL6R and MYC as Targeting Biomarkers in Imatinib-Resistant Chronic Myeloid Leukemia through Advanced Non-Invasive Apoptosis Detection Sensor Version 2 Detection.

Unveiling IL6R and MYC as Targeting Biomarkers in Imatinib-Resistant Chronic Myeloid Leukemia through Advanced Non-Invasive Apoptosis Detection Sensor Version 2 Detection.

Journal: Cells

Published: March 08, 2024

Interrogation of the interplay between DNA N6-methyladenosine (6mA) and hypoxia-induced chromatin accessibility by a randomized empirical model (EnrichShuf).

Interrogation of the interplay between DNA N6-methyladenosine (6mA) and hypoxia-induced chromatin accessibility by a randomized empirical model (EnrichShuf).

Journal: Nucleic acids research

Published: February 29, 2024

Mechanistic insights of lenvatinib: enhancing cisplatin sensitivity, inducing apoptosis, and suppressing metastasis in bladder cancer cells through EGFR/ERK/P38/NF-κB signaling inactivation.

Mechanistic insights of lenvatinib: enhancing cisplatin sensitivity, inducing apoptosis, and suppressing metastasis in bladder cancer cells through EGFR/ERK/P38/NF-κB signaling inactivation.

Journal: Cancer cell international

Published: October 26, 2023

Epigenetic regulation of asymmetric cell division by the LIBR-BRD4 axis.

Epigenetic regulation of asymmetric cell division by the LIBR-BRD4 axis.

Journal: Nucleic acids research

Published: April 12, 2023

Showing 1-12 of 44

Last Updated: 09/26/2026